FDCFDC Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹417.90
▼ 0.52%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)6,803.80
P/E24.14
P/B2.74
PEG0.14
ROE %11.81
ROCE %11.50
Debt / Equity0.01
EPS17.31
Revenue Growth %18.90
Profit Growth %166.80
Dividend Yield %1.20
Promoter Holding %69.95
FII Holding %7.19
DII Holding %—
Beta0.18
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Cup & Handle | LONG | 70% | ₹417.90 | ₹405.58 | ₹479.49 | 5.00 |
HOLDConviction 74%
The picture
- • Revenue growth: 18.9% YoY
- • Profit growth: 166.8% YoY
- • Debt/Equity: 0.01
- • RSI: 53
- • Price vs SMA50: above
- • Price vs SMA200: above
- • Cup & Handle signal (setup quality 70%)
Bull case
- • Revenue growth: 18.9% YoY
- • Profit growth: 166.8% YoY
- • Debt/Equity: 0.01
- • RSI: 53
Bear case
- • MACD: bearish
- • Price vs EMA21: below
- • Volume trend: 0.4x baseline
- • Max drawdown (1y): 36%
Key risks
- • MACD: bearish
- • Price vs EMA21: below
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹417.90
Stop Loss
₹399.96
risk 4.3%
Target 1 (1.5R)
₹444.81
+6.4%
Target 2 (3R)
₹471.72
+12.9%
Support (20d)
₹404.00
Resistance (52w)
₹521.15
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹17.94/share
ATR (volatility)
₹12.32
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹12.32). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
79
Technical
58
Momentum
71
Risk (safety)
61